Assembly Biosciences, Inc. (ASMB) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 6 Buy, 5 Hold.
The consensus price target is $40.00, representing an upside of 35.9% from the current price $29.44.
Analysts estimate Earnings Per Share (EPS) of $-6.76 and revenue of $0.03B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-6.69 vs est $-6.76 (beat +1%). 2025: actual $-0.55 vs est $-3.75 (beat +85.3%). Analyst accuracy: 0%.
ASMB Stock — 12-Month Price Forecast
$40.00
▲ +35.87% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Assembly Biosciences, Inc., the price target is $40.00.
The average price target represents a +35.87% change from the last price of $29.44.
ASMB Analyst Ratings
Buy
Based on 11 analysts giving stock ratings to Assembly Biosciences, Inc. in the past 3 months
EPS Estimates — ASMB
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$6.69
vs Est –$6.76
▲ 1.0% off
2025
Actual –$0.55
vs Est –$3.75
▲ 581.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — ASMB
69%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.029B
vs Est $0.025B
▲ 13.7% off
2025
Actual $0.072B
vs Est $0.037B
▲ 48.6% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
